Welcome to LookChem.com Sign In|Join Free
  • or
Methyl cis-3-hydroxycyclobutanecarboxylate, also known as MCHB, is a colorless liquid organic compound belonging to the cyclobutanecarboxylic acids class. It is characterized by a fruity odor and is widely recognized for its use as a flavoring agent in the food and beverage industry. Additionally, MCHB finds applications in perfume production and serves as a solvent in various industrial processes. Due to its potential health hazards and irritant properties, it is crucial to handle Methyl cis-3-hydroxycyclobutanecarboxylate with care and follow necessary safety precautions.

63485-50-7

Post Buying Request

63485-50-7 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

63485-50-7 Usage

Uses

Used in Food and Beverage Industry:
Methyl cis-3-hydroxycyclobutanecarboxylate is used as a flavoring agent for its fruity aroma, enhancing the taste and appeal of various food and beverage products.
Used in Perfume Production:
MCHB is utilized as a key ingredient in the creation of perfumes, contributing to the development of unique and pleasant fragrances.
Used in Industrial Processes as a Solvent:
In various industries, Methyl cis-3-hydroxycyclobutanecarboxylate is employed as a solvent, facilitating chemical reactions and processes due to its ability to dissolve other substances.

Check Digit Verification of cas no

The CAS Registry Mumber 63485-50-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,3,4,8 and 5 respectively; the second part has 2 digits, 5 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 63485-50:
(7*6)+(6*3)+(5*4)+(4*8)+(3*5)+(2*5)+(1*0)=137
137 % 10 = 7
So 63485-50-7 is a valid CAS Registry Number.

63485-50-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 15, 2017

Revision Date: Aug 15, 2017

1.Identification

1.1 GHS Product identifier

Product name 3-Hydroxy-1-cyclobutancarbonsaeuremethylester

1.2 Other means of identification

Product number -
Other names cis-Methyl 3-hydroxycyclobutanecarboxylate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:63485-50-7 SDS

63485-50-7Downstream Products

63485-50-7Relevant academic research and scientific papers

6-HETEROARYLOXY BENZIMIDAZOLES AND AZABENZIMIDAZOLES AS JAK2 INHIBITORS

-

Paragraph 0272-0273, (2021/11/13)

The present disclosure provides 6-heteroaryloxy benzimidazole and azabenzimidazole compounds and compositions thereof useful for inhibiting JAK2.

Method for synthesizing trans-3-hydroxy cyclobutyl formic acid

-

Paragraph 0047; 0048; 0052, (2018/07/06)

The invention belongs to the field of organic synthesis and discloses a method for synthesizing trans-3-hydroxy cyclobutyl formic acid. The method comprises the following steps: by using an appropriate reducing agent, reducing 3-carbonyl-cyclobutane formate (C1-C6 alkyl ester) into single trans-3-hydroxy cyclobutyl formic ether in an efficient stereoselectivity manner, and further performing a Mitsunobu reaction and hydrolysis, thereby obtaining single trans-3-hydroxy cyclobutyl formic acid. The method provided by the invention is high in synthesis method raw material availability, mild in reaction condition, good in stereoselectivity and relatively high in yield; in addition, aftertreatment and purification are both easy to operate, and the method is applicable to industrial amplified production.

1 -(CYCLOPENT-2-EN-1 -YL)-3-(2-HYDROXY-3-(ARYLSULFONYL)PHENYL)UREA DERIVATIVES AS CXCR2 INHIBITORS

-

Page/Page column 149, (2015/12/18)

The invention relates to 1-(3-sulfonylphenyl)-3-(cyclopent-2-en-1-yl)urea derivatives, and their use in treating or preventing diseases and conditions mediated by the CXCR2 receptor. In addition, the invention relates to compositions containing the derivatives and processes for their preparation.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 63485-50-7